
Feb 19 (Reuters) - Alzamend Neuro Inc ALZN.O:
ALZAMEND NEURO ANNOUNCES COMPLETION OF A NOVEL HEAD COIL BY TESLA FOR MEASURING BRAIN STRUCTURE LITHIUM LEVELS IN FIVE UPCOMING PHASE II CLINICAL TRIALS AT MASSACHUSETTS GENERAL HOSPITAL
Source text: ID:nBw3YrfS7a
Further company coverage: ALZN.O